Redeye sees another quarter in which OssDsign rolls out Catalyst full steam ahead. Sales were in line with our relatively optimistic forecast, with a stronger gross margin than anticipated. Our thesis of the company being a solid high-growth play is strengthened by the report. We reiterate our base case and note a hefty discount to its peers’ multiples.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/